Short Title:
Exploration Laboratory Analysis
Responsible HRP Element:
Exploration Medical Capability
Funding Status:
Terminated - A formerly active task that was stopped before its completion date due to deselection, descoping, reorganization etc.
|
Procurement Mechanism(s):
|
|
Aims:
Aims were not completed. No future flight projects related to lab analysis.
- To determine the operationally-relevant clinical analytes for exploration missions
- To develop Exploration Laboratory Analysis (ELA) platform(s) capable of measuring these analytes
- To develop assays for these analytes
- To demonstrate the ELA system in a ground environment (HERA or other ground analog)
- To demonstrate the ELA system in a flight environment (ISS)
- To demonstrate extended shelf-life and stability of reagents via accelerated aging studies
Category:
Technology or Tool
Subcategory:
Systems Solutions, Prototype Hardware or Software
Description:
The deliverable is a TRL 6 laboratory analysis system including assays for operationally-relevant clinical analytes and a platform capable of measuring them. The TRL 6 delivery will contribute to the closure of Gap Med13. The platform development is within current ExMC budget plan. The operational assay development is not within ExMC budget plan.
Internal Customers:
Exploration Medical Capability
External Customers:
None
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
The deliverables are the final report and data set from the accelerated aging study to determine the stability and shelf-life of the consumables and reagents. This study will contribute to the closure of Gap Med13.
Internal Customers:
Exploration Medical Capability
External Customers:
None
Category:
Technology or Tool
Subcategory:
Systems Solutions, Prototype Hardware or Software
Description:
The deliverable is a TRL 7 laboratory analysis system including assays for operationally-relevant clinical analyses and a platform capable of measuring them. The TRL 7 delivery will contribute to the closure of Gap Med13. The platform development is within current ExMC budget plan. The operational assay development is not within ExMC budget plan.
Internal Customers:
None
External Customers:
SCOD - Space and Clinical Operations Division
Is a Customer-Supplier Agreement (CSA) Required?
Yes